- $67.70m
- $22.29m
- 52
- 39
- 16
- 28
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.88 | 1.68 | 5.81 | 5.59 | 9.93 |
Operating Profit | -2.88 | -1.68 | -5.81 | -5.59 | -9.93 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.98 | -57.5 | -81.5 | 90 | 0.975 |
Net Income After Taxes | 3.98 | -57.5 | -81.5 | 90 | 0.975 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.98 | -57.5 | -81.5 | 90 | 0.975 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.98 | -57.5 | -97.4 | 90 | 0.975 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.005 | -0.037 | -0.035 | 0.017 | 0 |